You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
|
|---|---|
| Published in |
European Urology, October 2018
|
| DOI | 10.1016/j.eururo.2018.09.002 |
| Pubmed ID | |
| Authors |
Eugene J Pietzak, Emily C Zabor, Aditya Bagrodia, Joshua Armenia, Wenhuo Hu, Ahmet Zehir, Samuel Funt, Francois Audenet, David Barron, Noelia Maamouri, Qiang Li, Min Yuen Teo, Maria E Arcila, Michael F Berger, Nikolaus Schultz, Guido Dalbagni, Harry W Herr, Dean F Bajorin, Jonathan E Rosenberg, Hikmat Al-Ahmadie, Bernard H Bochner, David B Solit, Gopa Iyer |
X Demographics
The data shown below were collected from the profiles of 94 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 29 | 31% |
| France | 9 | 10% |
| Spain | 5 | 5% |
| Brazil | 4 | 4% |
| Denmark | 2 | 2% |
| Mexico | 2 | 2% |
| Colombia | 2 | 2% |
| Germany | 2 | 2% |
| Turkey | 2 | 2% |
| Other | 12 | 13% |
| Unknown | 25 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 43 | 46% |
| Scientists | 29 | 31% |
| Practitioners (doctors, other healthcare professionals) | 16 | 17% |
| Science communicators (journalists, bloggers, editors) | 6 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 97 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 11 | 11% |
| Researcher | 11 | 11% |
| Student > Ph. D. Student | 10 | 10% |
| Student > Doctoral Student | 8 | 8% |
| Student > Master | 8 | 8% |
| Other | 22 | 23% |
| Unknown | 27 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 44% |
| Biochemistry, Genetics and Molecular Biology | 9 | 9% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Unspecified | 2 | 2% |
| Other | 4 | 4% |
| Unknown | 34 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 59. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2021.
All research outputs
#717,197
of 25,385,509 outputs
Outputs from European Urology
#331
of 6,218 outputs
Outputs of similar age
#15,555
of 354,817 outputs
Outputs of similar age from European Urology
#21
of 135 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,218 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,817 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.